# FDA Inspection 1314218 - Tissuegenx LLC - April 20, 2026

Source: https://www.keypedia.com/records/fda_inspections/tissuegenx-llc/b34e4451-e888-4294-86ff-74fffb0a469a
Source feed: FDA_Inspections

> FDA Inspection 1314218 for Tissuegenx LLC on April 20, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1314218
- Company Name: Tissuegenx LLC
- Inspection Date: 2026-04-20
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

Company: https://www.keypedia.com/companies/tissuegenx-llc/646876bc-a8fa-47b0-89ef-26855a49d805

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d